Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Alessandro, Rimondi"'
Autor:
Matilde Topa, Alessandro Rimondi, Andrea Sorge, Veronica Smania, Lucia Scaramella, Nicoletta Nandi, Flaminia Cavallaro, Maurizio Vecchi, Luca Elli, Gian Eugenio Tontini
Publikováno v:
Endoscopy International Open, Vol 12, Iss 07, Pp E842-E848 (2024)
Externí odkaz:
https://doaj.org/article/e77dd3a7582d47fab716dddd3164d034
Autor:
Alberto Murino, Alessandro Rimondi
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 4, Pp 198-199 (2024)
Externí odkaz:
https://doaj.org/article/0814fb4a0a3a42b2927a6701eedbb37f
Autor:
Stefano Mazza, Nicole Piazza O. Sed, Francesco Simone Conforti, Alberto Fascì, Alessandro Rimondi, Beatrice Marinoni, Valentina Casini, Chiara Ricci, Francesca Munari, Lorena Pirola, Pietro Invernizzi, Carlo Girelli, Guido Lupinacci, Luca Pastorelli, Flaminia Cavallaro, Luca Ferraris, Alice Colucci, Arnaldo Amato, Gian Eugenio Tontini, Maurizio Vecchi, Gionata Fiorino, Flavio Caprioli
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 172-181 (2022)
Abstract Data regarding double switching from originator infliximab (IFX) to IFX biosimilars in inflammatory bowel diseases (IBDs) are lacking. The purpose of this study was to evaluate the safety and efficacy of switching from originator IFX to CT
Externí odkaz:
https://doaj.org/article/e03578acc9754c6fb34334e43c6266ac
Autor:
Gian Eugenio Tontini, Lorenzo Dioscoridi, Alessandro Rimondi, Paolo Cantù, Flaminia Cavallaro, Aurora Giannetti, Luca Elli, Luca Pastorelli, Francesco Pugliese, Massimiliano Mutignani, Maurizio Vecchi
Publikováno v:
Endoscopy International Open, Vol 10, Iss 04, Pp E386-E393 (2022)
Objectives and study aims Recent pilot studies have assessed the feasibility of a novel 1.9-/1.5-μm dual emission endoscopic laser treatment (1.9-/1.5-μmDEELT) for endoscopic hemostasis, ablation and resection. In this study, we investigated the sa
Externí odkaz:
https://doaj.org/article/8c21fe9c59d6444fbbb48bf086318eb2
Autor:
Gian Eugenio Tontini, Alessandro Rimondi, Marta Vernero, Helmut Neumann, Maurizio Vecchi, Cristina Bezzio, Flaminia Cavallaro
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Introduction: Since the advent of artificial intelligence (AI) in clinical studies, luminal gastrointestinal endoscopy has made great progress, especially in the detection and characterization of neoplastic and preneoplastic lesions. Several studies
Externí odkaz:
https://doaj.org/article/8f90bd8052d3480d8741099fd69b6ebe
Autor:
Luca Elli, Beatrice Marinoni, Reena Sidhu, Christian Bojarski, Federica Branchi, Gian Eugenio Tontini, Stefania Chetcuti Zammit, Sherine Khater, Rami Eliakim, Emanuele Rondonotti, Jean Cristhophe Saurin, Mauro Bruno, Juliane Buchkremer, Sergio Cadoni, Flaminia Cavallaro, Xavier Dray, Pierre Ellul, Ignacio Fernandez Urien, Martin Keuchel, Uri Kopylov, Anastasios Koulaouzidis, Romain Leenhardt, Peter Baltes, Hanneke Beaumont, Clelia Marmo, Deirdre McNamara, Alessandro Mussetto, Artur Nemeth, Enrique Perez Cuadrado Robles, Guillame Perrod, Gabriel Rahmi, Maria Elena Riccioni, Alexander Robertson, Cristiano Spada, Ervin Toth, Konstantinos Triantafyllou, Gabriele Wurm Johansson, Alessandro Rimondi
Publikováno v:
Diagnostics, Vol 12, Iss 7, p 1704 (2022)
(1) Background: Villous atrophy is an indication for small bowel capsule endoscopy (SBCE). However, SBCE findings are not described uniformly and atrophic features are sometimes not recognized; (2) Methods: The Delphi technique was employed to reach
Externí odkaz:
https://doaj.org/article/cd139ab09e59444d90f16bebacef0bc3
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 13, Iss 1 (2021)
Anemia is a global health problem affecting one-third of the world population, and half of the cases are due to iron deficiency (ID). Iron de?ciency anemia (IDA) is the leading cause of disability in several countries. The causes of ID and IDA can be
Externí odkaz:
https://doaj.org/article/2518adb5e39c4b17925a6a8c5fbda3fc
Autor:
Marietta, Iacucci, Rosanna, Cannatelli, Tommaso Lorenzo, Parigi, Olga M, Nardone, Gian Eugenio, Tontini, Nunzia, Labarile, Andrea, Buda, Alessandro, Rimondi, Alina, Bazarova, Raf, Bisschops, Rocio, Del Amor, Pablo, Meseguer, Valery, Naranjo, PICaSSO, Group, Subrata, Ghosh, Enrico, Grisan
Publikováno v:
Endoscopy. 55:332-341
Background Endoscopic and histological remission (ER, HR) are therapeutic targets in ulcerative colitis (UC). Virtual chromoendoscopy (VCE) improves endoscopic assessment and the prediction of histology; however, interobserver variability limits stan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a34c0202700e2f1ab3be7aaeaf4872
https://doi.org/10.1055/a-1960-3645
https://doi.org/10.1055/a-1960-3645
Autor:
Alberto, Murino, Alessandro, Rimondi
Publikováno v:
Gastrointestinal Endoscopy. 97:347-349
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57141399e14237c9a3382b634403cf70
https://doi.org/10.1016/j.gie.2022.10.010
https://doi.org/10.1016/j.gie.2022.10.010
Autor:
Elena Trombetta, Marta Borghi, Antonio Bertoletti, Maria Manunta, E. Farina, Christine Y.L. Tham, Alessandro Rimondi, Fabien Zoulim, Alessandro Loglio, Riccardo Perbellini, Pietro Lampertico, Caroline Scholtes, Florian van Bömmel, Peter Ferenci, Sara Colonia Uceda Renteria, Heidemarie Holzmann, Ferruccio Ceriotti, Laura Porretti, Daniele Prati
Publikováno v:
Journal of Hepatology. 76:464-469
The entry-inhibitor Bulevirtide (BLV) received conditional approval by EMA in July 2020 for the treatment of adult patients with compensated chronic hepatitis Delta. However, the effectiveness and safety of BLV administered as monotherapy beyond 48 w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::413f3462d676be957b66b4be04009bb5
https://doi.org/10.1016/j.jhep.2021.10.012
https://doi.org/10.1016/j.jhep.2021.10.012